MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanomaCamille Niveau(Centre National de la Recherche Scientifique), Caroline Aspord(GenVec)Nature CommunicationsJanuary 27, 202510.1038/s41467-025-56392-xCited by 33SaveCiteExport RISWatch citationsRelated PapersDysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes|Clinical & Translational Immunology|2021|11